Page 28 - EJMO-9-2
P. 28

Eurasian Journal of
            Medicine and Oncology                                                    Gut microbiome effects on obesity



            including polyphenols. One of their main roles is to   to a decrease in fat-free mass (0.8 kg). However, fat mass
            prevent the digestion fats and carbohydrates from food.   remained unchanged.  The mechanisms underlying
                                                                                 65
            This is due to their ability to block some digestive enzymes   this association remain unclear and require further
            responsible for breaking down nutrients, such as pancreatic   clarification.
            lipase, which helps digest fats, and amylases, which break   New medications have recently emerged to treat obesity
            down carbohydrates into sugars that the body can absorb. 55
                                                               and promote weight loss. Semaglutide and tirzepatide are
              During Ramadan, dietary habits and fasting programs   two well-known drugs currently used to treat obesity.
            change. Ramadan intermittent fasting (RIF) affects gut   Semaglutide, a GLP‐1 analog, imitates the effects of native
            hormones, including leptin, and ghrelin, GLP-1. RIF has   GLP‐1, improving glycemic control and promoting weight
            proven to be an effective strategy to modulate appetite-  loss by decreasing caloric intake, reducing hunger, and
            regulating hormones, resulting in improved body    increasing satiety and satiation.  In patients suffering
                                                                                          66
            composition indices and a reduction in obesity. 56  from obesity-related heart failure with preserved ejection
              Certain bioactive compounds, including curcumin and   fraction and T2D, semaglutide resulted in greater declines
            zinc, have shown promising effects in obesity management.   in heart failure symptoms and significant weight loss
                                                                                       67
            Curcumin has demonstrated strong anti-inflammatory   than the placebo after 1 year.  Another study found that
            effects related to obesity. An umbrella review indicated   participants receiving 2.4  mg of semaglutide per week
                                                         57
            that curcumin intake could reduce WC, BMI, and BW.    experienced an average BW reduction of 15.3 kg. 68
            Moreover, the intake of curcumin, curcuminoids, or   Similarly, the effects of tirzepatide have been
            turmeric has demonstrated notable anti-inflammatory   investigated. A  recent systematic review and meta-
            properties.  Individuals  consuming  different  amounts  of   analysis of randomized controlled trials discovered the
            these three compounds exhibited reductions in C-reactive   positive effect of tirzepatide. The weekly treatment with
            protein (CRP), tumor necrosis factor-alpha (TNF-α), and   tirzepatide resulted in significant increase in BW and lower
            interleukin  (IL)-6.   Furthermore,  zinc  and  resveratrol   hemoglobin A1C levels, without a significant increase in
                           58
            have shown promising potential in modulating leptin   serious or life-threatening adverse events. 69
            levels and glucose signaling, which may have beneficial
            effects on energy regulation in obese individuals and   Colchicine  is  another  pharmaceutical  drug  known
            cardiovascular health. However, a longer exposure time is   to reduce inflammation in multiple diseases. It has the
            suggested to be necessary to fully assess their impact on   ability to reduce inflammatory markers, including CRP,
            energy homeostasis. 59                             glycoprotein acetylation, and certain inflammatory
                                                               cytokine serum concentrations. 70-72  In the context of
              Obesity is one of the major metabolic syndromes   obesity, colchicine has shown a considerable effect on
            (MetSyn).  Significant weight loss is considered the   leukocyte populations implicated in both innate and
                    7
            primary and only curative treatment to address MetSyn,   adaptive immune responses. 73
            as it can influence many of its components. In addition to
            high-dose GPL-1RAs, new medical treatment options are   To enhance nutrition and public health, more  than
            being developed to manage MetSyn. These include dual   45 countries have imposed taxes on sugar-sweetened
            or triple hormonal agonists targeting the GLP-1, glucose-  beverages.  In several nations, these taxes have been related
                                                                       74
            dependent insulinotropic polypeptide (GIP), and glucagon   to higher pricing and reduced sales and consumption of
            receptors. GLP-1 plays a role in controlling blood sugar   taxed beverages.  A significant decrease in the purchase
                                                                            75
            and appetite, while GIP works alongside GLP-1 to enhance   of these beverages and obesity rates has been observed
            insulin sensitivity, and glucagon helps regulate blood sugar   in  middle-  and  upper-middle-income  countries.  These
            levels. 60,61  In addition, leptin, a key hormone in appetite   findings confirm that imposing high taxes on SBBs could
            regulation, plays an essential role in regulating appetite   be an effective solution to combat obesity and related
            and energy balance, which can influence BW and obesity. 62  health risks. 76

              In this regard, researchers have investigated the effects   3. GM
            of various medications on weight loss. Levothyroxine, a
            medication used as a substitute for thyroid hormones,  is   The GM consists of a community of microorganisms,
                                                       63
            administered to restore hormonal balance.  Results have   including viruses, bacteria, archaea, and fungi, residing
                                              64
            shown  that  after  6  months  of  levothyroxine  treatment   within the gastrointestinal tract (GIT), with bacteria
            in  individuals  with  hypothyroidism,  resting  energy   reign over this niche. 77,78  Most of these microorganisms
            expenditure increased, which suggests that bodies are   predominantly inhabit the large intestine. 79,80  The most
            burning more calories. This resulted in weight loss due   dominant and prevalent bacterial phyla within the gut


            Volume 9 Issue 2 (2025)                         20                              doi: 10.36922/ejmo.8318
   23   24   25   26   27   28   29   30   31   32   33